• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于凝胶过滤法的维持性血液透析患者钙磷颗粒的中期预测价值。

Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay.

机构信息

Department of Cardiology, Saitama Medical University, International Medical Center, Saitama, Japan.

Department of Cardiology, Saitama Medical University, International Medical Center, Saitama, Japan.

出版信息

Atherosclerosis. 2020 Jun;303:46-52. doi: 10.1016/j.atherosclerosis.2020.03.016. Epub 2020 Mar 21.

DOI:10.1016/j.atherosclerosis.2020.03.016
PMID:32307113
Abstract

BACKGROUND AND AIMS

Calciprotein particles (CPPs), nano-aggregates containing fetuin-A-bound calcium-phosphate, are associated with aortic stiffness and coronary calcification in maintenance hemodialysis patients. A novel gel-filtration assay can detect low-density small CPPs, which are actually a major form of circulating CPPs in vivo. We sought to investigate whether circulating CPP levels measured by gel-filtration method would accurately predict hard endpoints in maintenance hemodialysis patients.

METHODS

This study used a prospective, multicenter, longitudinal, and observational design. One-hundred eight patients enrolled in this study were followed-up for about 2 years. We reported all-cause death and cardiovascular events, which included major adverse cardiac, cerebrovascular, and limb events.

RESULTS

Kaplan-Meier analysis showed no significant difference between patients with the higher (>median) and lower (<median) CPP levels with regard to all-cause death. However, the higher CPP group showed a higher incidence of cardiovascular events (log-rank test χ = 4.41, p = 0.036). Univariate Cox regression analysis revealed that CPP levels were not associated with all-cause death, but were significantly associated with higher incidence of cardiovascular events (hazard ratio (HR) 1.03, 95% confidence interval (CI) [1.02-1.05], p < 0.001) for every thousand CPP increase. Multivariate Cox regression analysis revealed that CPP levels were not associated with all-cause death, but were independently associated with cardiovascular events (HR 1.03, 95% CI [1.01-1.04], p < 0.001) for every thousand CPP.

CONCLUSIONS

This finding suggests a potential predictive value of CPPs in maintenance hemodialysis patients.

摘要

背景与目的

含有结合了胎球蛋白 A 的钙磷的钙磷蛋白颗粒(CPPs)与维持性血液透析患者的主动脉僵硬和冠状动脉钙化有关。一种新的凝胶过滤分析可以检测到低浓度的小 CPPs,这些 CPPs 实际上是体内循环 CPPs 的主要形式。我们试图研究通过凝胶过滤法测量的循环 CPP 水平是否能准确预测维持性血液透析患者的硬终点。

方法

本研究采用前瞻性、多中心、纵向和观察性设计。108 名患者参与了这项研究,随访时间约为 2 年。我们报告了全因死亡和心血管事件,包括主要的不良心脏、脑血管和肢体事件。

结果

Kaplan-Meier 分析显示,CPP 水平较高(>中位数)和较低(<中位数)的患者在全因死亡方面没有显著差异。然而,CPP 较高的组心血管事件的发生率较高(对数秩检验 χ2=4.41,p=0.036)。单因素 Cox 回归分析显示,CPP 水平与全因死亡无关,但与心血管事件的发生率显著相关(危险比(HR)1.03,95%置信区间(CI)[1.02-1.05],p<0.001),每增加 1000 个 CPP。多因素 Cox 回归分析显示,CPP 水平与全因死亡无关,但与心血管事件独立相关(HR 1.03,95% CI [1.01-1.04],p<0.001),每增加 1000 个 CPP。

结论

这一发现表明 CPP 在维持性血液透析患者中有潜在的预测价值。

相似文献

1
Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay.基于凝胶过滤法的维持性血液透析患者钙磷颗粒的中期预测价值。
Atherosclerosis. 2020 Jun;303:46-52. doi: 10.1016/j.atherosclerosis.2020.03.016. Epub 2020 Mar 21.
2
Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.血清钙磷复合物颗粒大小和转化时间与新发生血液透析患者动脉钙化、动脉僵硬度和死亡率的相关性。
Am J Kidney Dis. 2021 Mar;77(3):346-354. doi: 10.1053/j.ajkd.2020.05.031. Epub 2020 Aug 13.
3
Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.磷酸化胎球蛋白 A 含钙化蛋白颗粒与透析前 CKD 患者的主动脉僵硬和促钙化环境有关。
Nephrol Dial Transplant. 2012 May;27(5):1957-66. doi: 10.1093/ndt/gfr609. Epub 2011 Nov 20.
4
The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients.碳酸镧对血液透析患者钙磷蛋白颗粒的影响。
Clin Exp Nephrol. 2020 Apr;24(4):323-329. doi: 10.1007/s10157-019-01832-4. Epub 2019 Dec 26.
5
Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.使用荧光双膦酸盐定量血清/血浆样本中的钙磷蛋白颗粒 (CPPs)。
Methods Mol Biol. 2023;2664:333-341. doi: 10.1007/978-1-0716-3179-9_21.
6
The effects for inflammatory responses by CPP with different colloidal properties in hemodialysis patients.不同胶体特性 CPP 在血液透析患者中对炎症反应的影响。
Sci Rep. 2022 Dec 17;12(1):21856. doi: 10.1038/s41598-022-26166-2.
7
Serum calciprotein particle-to-phosphate ratio as a predictor of cardiovascular events in incident hemodialysis patients.血清钙蛋白颗粒与磷酸盐比值作为新发血液透析患者心血管事件的预测指标
Ther Apher Dial. 2025 Apr;29(2):178-188. doi: 10.1111/1744-9987.14203. Epub 2024 Sep 4.
8
Novel assessments of systemic calcification propensity.系统性钙化倾向的新型评估方法。
Curr Opin Nephrol Hypertens. 2016 Jul;25(4):278-84. doi: 10.1097/MNH.0000000000000237.
9
Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial.司维拉姆对血液透析患者钙蛋白颗粒的影响:司维拉姆与钙降低透析中含胎球蛋白A的钙蛋白颗粒(SCaRF)随机对照试验
Kidney Int Rep. 2020 Jun 29;5(9):1432-1447. doi: 10.1016/j.ekir.2020.06.014. eCollection 2020 Sep.
10
Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.鉴定和量化慢性肾脏病患者血浆中具有不同物理特性的钙磷复合物颗粒。
Sci Rep. 2018 Jan 19;8(1):1256. doi: 10.1038/s41598-018-19677-4.

引用本文的文献

1
Calciprotein particle-activated endothelial cells aggravate smooth muscle cell calcification via paracrine signalling.钙蛋白颗粒激活的内皮细胞通过旁分泌信号传导加重平滑肌细胞钙化。
Cell Mol Life Sci. 2025 Apr 26;82(1):177. doi: 10.1007/s00018-025-05702-z.
2
Simultaneous Measurement of Calciprotein Particles with Different Assays and Clinical Outcomes in CKD.在慢性肾脏病中使用不同检测方法同时测量钙蛋白颗粒及其临床结局
Kidney360. 2025 Apr 1;6(4):550-560. doi: 10.34067/KID.0000000700. Epub 2025 Jan 16.
3
The formation and function of calciprotein particles.
钙蛋白颗粒的形成与功能。
Pflugers Arch. 2025 Jun;477(6):753-772. doi: 10.1007/s00424-025-03083-7. Epub 2025 Apr 23.
4
The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients.依特卡肽治疗降低甲状旁腺激素对血液透析患者钙化倾向和钙蛋白颗粒的影响。
Clin Kidney J. 2024 Mar 30;17(6):sfae097. doi: 10.1093/ckj/sfae097. eCollection 2024 Jun.
5
Association of calciprotein particles with serum phosphorus among patients undergoing conventional and extended-hours haemodialysis.接受常规和非工作时间血液透析患者中钙磷蛋白颗粒与血清磷的关联
Clin Kidney J. 2024 May 6;17(6):sfae121. doi: 10.1093/ckj/sfae121. eCollection 2024 Jun.
6
Risk factors for short-term all-cause mortality in patients with end stage renal disease: a scoping review.终末期肾病患者短期全因死亡率的风险因素:范围综述。
BMC Nephrol. 2024 Feb 27;25(1):71. doi: 10.1186/s12882-024-03503-3.
7
Calciprotein Particles Induce Cellular Compartment-Specific Proteome Alterations in Human Arterial Endothelial Cells.钙蛋白颗粒诱导人动脉内皮细胞中特定细胞区室的蛋白质组改变。
J Cardiovasc Dev Dis. 2023 Dec 22;11(1):5. doi: 10.3390/jcdd11010005.
8
Inflammation and gut dysbiosis as drivers of CKD-MBD.炎症和肠道菌群失调作为 CKD-MBD 的驱动因素。
Nat Rev Nephrol. 2023 Oct;19(10):646-657. doi: 10.1038/s41581-023-00736-7. Epub 2023 Jul 24.
9
The effects for inflammatory responses by CPP with different colloidal properties in hemodialysis patients.不同胶体特性 CPP 在血液透析患者中对炎症反应的影响。
Sci Rep. 2022 Dec 17;12(1):21856. doi: 10.1038/s41598-022-26166-2.
10
Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.蔗糖铁氧羟化物对透析患者内源性钙磷复合物、炎症和血管细胞的影响。
Nephrol Dial Transplant. 2023 May 4;38(5):1282-1296. doi: 10.1093/ndt/gfac271.